ATOSSA THERAPEUTICS INC

ATOS NASDAQ

without_worries

*risky but the reward…* Trawling through the Nasdaq at the 11th hour before a major correction reveals a number of interesting opportunities where the success of tech stocks have overshadowed the less successful of late. This trade idea is 100% technical without focus on the fundamentals. Atossa is a small Therapeutics business with a limited number of...

banjo_nz

Few things i noticed: Volume is thinning out MACD is curling ADX higher highs is lower than the former and heading downwards. DI+ crossed over ADX. However, StochRSI says its oversold Fundamentally it is driven by the following reasons: Has COVID19 Drug candidate. Low FLOAT: 9.8M shares. Based from these indicators, I suspect that the best...

KozakHlib

Contextual immersion trading strategy idea. Atossa Therapeutics, Inc. develops and markets medical devices, laboratory tests, and therapeutics to address breast health conditions in the United States. The share price rose after announcing the availability of the CEO's 158-page book "Your COVID-19 Survival Manual: A Physician's Guide to Keep You and Your Family...

KozakHlib

Contextual immersion trading strategy idea. The demand for shares of Atossa Therapeutics looks higher than the supply. The company develops and markets medical devices, laboratory tests, and therapeutics to address breast health conditions. Due to the spread of COVID-19, the demand for the company`s services rose. This and other conditions can cause a rise in...

lfraksiya

Hi Good to know. Be ready.

htjohn

ATOS Short Term Prediction. Spotted Cup & Handle for ATOS. The RSI dipped below 50 with MACD histogram showing good progress of moving towards the 0 line. Entry in the 1.50’s is a good buy before it jumps above 2$ within a week or two.

SonalSignals2018

ATOS: Atossa Genetics Inc. 2019-12-19 08:30:10 Atossa Genetics Announces Phase 2 Study Contract for Oral Endoxifen to Reduce Mammographic Breast Density in Women

InsiderFinancial

About Atossa Genetics Atossa Genetics Inc. is a clinical-stage biopharmaceutical company developing novel therapeutics and delivery methods to treat breast cancer and other breast conditions.

Note7Creole

Atossa Genetics’ Preliminary Phase 2 Study Achieves Primary Endpoint: Topical Endoxifen Rapidly Reduces Breast Density This is what we are looking for, go long with this CV company. Find a good entry point and squat!! If FDA approved this will go back where it cam from $$$

PennyStock101

The rumor mill continues to spin in ATOS prior to a presentation scheduled for April the 25th, the spike in volume hopefully preempts a positive move. Keep it on the watchlist.

OneUmbrellaGroup

Trade Details Provided on Chart.

Prestoned

....

SanderSalomonsen

description on chart.

AzrulAzir

Atossa Genetics Inc. is a clinical-stage biopharmaceutical company developing novel therapeutics and delivery methods to treat breast cancer and other breast conditions, yesterday FDA Aprroved Oral Endoxifen for breast cancer patient. Endoxifen is an active metabolite of tamoxifen, which is an FDA-approved drug to prevent new as well as recurrent disease in breast...

BenjaPaulP

$10 target is picked because thats where 200 SMA is at.

BenjaPaulP

ATOS is making a double bottom and is about to break out soon.

Prestoned

who doesnt like generic epi pens …. current level and under seem legit enough for the risk.

schmidtke_jake

look for a long after breaking of trend and pull back to the level it broke up, if this level holds should be good indication of going up to the next levels.